Reply to @Boffin99
I am not sure I understand your question. Are you asking if the sensitivity shown in those mutations is a result of FTO inhibition?
I was just quoting Dr Verrill's paper. I saw from the ASH abstract that KRAS was an identified mutation in Case Study 1 and I'm speculating that they may have found other mutations in the same study like NRAS and KIT which seem to also be associated with AML. I could be completely wrong, chatgpt is likely dangerous in the wrong hands...
Ann: Zantrene highly effective in EMD AML Mouse Model, page-115
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.70 |
Change
0.090(5.59%) |
Mkt cap ! $289.5M | |||
| Open | High | Low | Value | Volume |
| $1.60 | $1.76 | $1.59 | $142.7K | 84.97K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 17175 | $1.70 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.77 | 6060 | 1 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |